Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF is a research paper published in Diabetes Care (2020). On theSindex it has a DataRank of 2.7. It has been cited 76 times, with 59 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.652
From this paper's citation signal
Citation Network Contribution
2.0
From 46 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 59 citers.
British Heart Foundation
Grant: RE/18/6/34217
AstraZeneca
MeSH Terms